Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Condliffe, Robin"'
Autor:
Alkhanfar D; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom.; INSIGNEO, Institute for in Silico Medicine, University of Sheffield, Sheffield, United Kingdom.; Department of Clinical Radiology, Sheffield Teaching Hospitals, Sheffield, United Kingdom., Dwivedi K; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom., Alandejani F; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom., Shahin Y; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom.; Department of Clinical Radiology, Sheffield Teaching Hospitals, Sheffield, United Kingdom., Alabed S; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom.; Department of Clinical Radiology, Sheffield Teaching Hospitals, Sheffield, United Kingdom., Johns C; Department of Clinical Radiology, Sheffield Teaching Hospitals, Sheffield, United Kingdom., Garg P; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom., Thompson AAR; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom.; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom., Rothman AMK; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom.; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom., Hameed A; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom., Charalampopoulos A; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom., Wild JM; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom.; INSIGNEO, Institute for in Silico Medicine, University of Sheffield, Sheffield, United Kingdom., Condliffe R; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom., Kiely DG; INSIGNEO, Institute for in Silico Medicine, University of Sheffield, Sheffield, United Kingdom.; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom., Swift AJ; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom.; INSIGNEO, Institute for in Silico Medicine, University of Sheffield, Sheffield, United Kingdom.
Publikováno v:
Frontiers in cardiovascular medicine [Front Cardiovasc Med] 2023 Apr 17; Vol. 10, pp. 1016994. Date of Electronic Publication: 2023 Apr 17 (Print Publication: 2023).
Autor:
Macdonald A; Department of Infection, Immunity and Cardiovascular Disease, The University of Sheffield, Sheffield, United Kingdom.; Department of Clinical Radiology, Sheffield Teaching Hospitals, Sheffield, United Kingdom., Salehi M; Department of Infection, Immunity and Cardiovascular Disease, The University of Sheffield, Sheffield, United Kingdom.; Department of Clinical Radiology, Sheffield Teaching Hospitals, Sheffield, United Kingdom., Alabed S; Department of Infection, Immunity and Cardiovascular Disease, The University of Sheffield, Sheffield, United Kingdom.; Department of Clinical Radiology, Sheffield Teaching Hospitals, Sheffield, United Kingdom.; INSIGNEO, Institute for in Silico Medicine, The University of Sheffield, Sheffield, United Kingdom., Maiter A; Department of Infection, Immunity and Cardiovascular Disease, The University of Sheffield, Sheffield, United Kingdom.; Department of Clinical Radiology, Sheffield Teaching Hospitals, Sheffield, United Kingdom., Goh ZM; Department of Infection, Immunity and Cardiovascular Disease, The University of Sheffield, Sheffield, United Kingdom.; Department of Clinical Radiology, Sheffield Teaching Hospitals, Sheffield, United Kingdom., Dwivedi K; Department of Infection, Immunity and Cardiovascular Disease, The University of Sheffield, Sheffield, United Kingdom.; Department of Clinical Radiology, Sheffield Teaching Hospitals, Sheffield, United Kingdom., Johns C; Department of Infection, Immunity and Cardiovascular Disease, The University of Sheffield, Sheffield, United Kingdom., Cogliano M; Department of Infection, Immunity and Cardiovascular Disease, The University of Sheffield, Sheffield, United Kingdom., Alandejani F; Department of Infection, Immunity and Cardiovascular Disease, The University of Sheffield, Sheffield, United Kingdom., Condliffe R; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield, United Kingdom., Wild JM; Department of Infection, Immunity and Cardiovascular Disease, The University of Sheffield, Sheffield, United Kingdom., Kiely DG; Department of Infection, Immunity and Cardiovascular Disease, The University of Sheffield, Sheffield, United Kingdom.; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield, United Kingdom., Garg P; Norwich Medical School, University of East Anglia, Norwich, United Kingdom., Swift AJ; Department of Infection, Immunity and Cardiovascular Disease, The University of Sheffield, Sheffield, United Kingdom.; INSIGNEO, Institute for in Silico Medicine, The University of Sheffield, Sheffield, United Kingdom.
Publikováno v:
Frontiers in cardiovascular medicine [Front Cardiovasc Med] 2023 Jan 04; Vol. 9, pp. 1037385. Date of Electronic Publication: 2023 Jan 04 (Print Publication: 2022).
Autor:
Sharkey MJ; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom.; 3D Imaging Lab, Sheffield Teaching Hospitals NHSFT, Sheffield, United Kingdom., Taylor JC; 3D Imaging Lab, Sheffield Teaching Hospitals NHSFT, Sheffield, United Kingdom., Alabed S; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom., Dwivedi K; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom.; Insigneo Institute for in Silico Medicine, University of Sheffield, Sheffield, United Kingdom., Karunasaagarar K; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom.; Radiology Department, Sheffield Teaching Hospitals NHSFT, Sheffield, United Kingdom., Johns CS; Radiology Department, Sheffield Teaching Hospitals NHSFT, Sheffield, United Kingdom., Rajaram S; Radiology Department, Sheffield Teaching Hospitals NHSFT, Sheffield, United Kingdom., Garg P; Norwich Medical School, University of East Anglia, Norwich, United Kingdom., Alkhanfar D; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom., Metherall P; 3D Imaging Lab, Sheffield Teaching Hospitals NHSFT, Sheffield, United Kingdom., O'Regan DP; MRC London Institute of Medical Sciences, Imperial College London, London, United Kingdom., van der Geest RJ; Department of Radiology, Leiden University Medical Center, Leiden, Netherlands., Condliffe R; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom.; Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals NHS Trust, Sheffield, United Kingdom., Kiely DG; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom.; Insigneo Institute for in Silico Medicine, University of Sheffield, Sheffield, United Kingdom.; Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals NHS Trust, Sheffield, United Kingdom., Mamalakis M; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom.; Insigneo Institute for in Silico Medicine, University of Sheffield, Sheffield, United Kingdom.; Department of Computer Science, University of Sheffield, Sheffield, United Kingdom., Swift AJ; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom.; Insigneo Institute for in Silico Medicine, University of Sheffield, Sheffield, United Kingdom.
Publikováno v:
Frontiers in cardiovascular medicine [Front Cardiovasc Med] 2022 Sep 26; Vol. 9, pp. 983859. Date of Electronic Publication: 2022 Sep 26 (Print Publication: 2022).
Autor:
Alandejani F; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom., Hameed A; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom.; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom., Tubman E; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom., Alabed S; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom.; Institute for in silico Medicine (INSIGNEO), University of Sheffield, Sheffield, United Kingdom., Shahin Y; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom.; Institute for in silico Medicine (INSIGNEO), University of Sheffield, Sheffield, United Kingdom., Lewis RA; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom.; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom., Dwivedi K; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom., Mahmood A; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom., Middleton J; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom.; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom., Watson L; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom., Alkhanfar D; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom., Johns CS; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom., Rajaram S; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom., Garg P; Norwich Medical School, University of East Anglia, Norwich, United Kingdom., Condliffe R; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom., Elliot CA; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom., Thompson AAR; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom.; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom., Rothman AMK; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom.; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom.; Institute for in silico Medicine (INSIGNEO), University of Sheffield, Sheffield, United Kingdom., Charalampopoulos A; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom., Lawrie A; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom., Wild JM; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom.; Institute for in silico Medicine (INSIGNEO), University of Sheffield, Sheffield, United Kingdom., Swift AJ; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom.; Institute for in silico Medicine (INSIGNEO), University of Sheffield, Sheffield, United Kingdom., Kiely DG; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom.; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom.; Institute for in silico Medicine (INSIGNEO), University of Sheffield, Sheffield, United Kingdom.
Publikováno v:
Frontiers in cardiovascular medicine [Front Cardiovasc Med] 2022 Mar 25; Vol. 9, pp. 797561. Date of Electronic Publication: 2022 Mar 25 (Print Publication: 2022).
Autor:
Shahin Y; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom.; Department of Clinical Radiology, Sheffield Teaching Hospitals NHS FT, Sheffield, United Kingdom., Alabed S; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom.; Department of Clinical Radiology, Sheffield Teaching Hospitals NHS FT, Sheffield, United Kingdom., Rehan Quadery S; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS FT, Sheffield, United Kingdom., Lewis RA; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS FT, Sheffield, United Kingdom., Johns C; Department of Clinical Radiology, Sheffield Teaching Hospitals NHS FT, Sheffield, United Kingdom., Alkhanfar D; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom., Sukhanenko M; Department of Clinical Radiology, Sheffield Teaching Hospitals NHS FT, Sheffield, United Kingdom., Alandejani F; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom., Garg P; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom., Elliot CA; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS FT, Sheffield, United Kingdom., Hameed A; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom.; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS FT, Sheffield, United Kingdom., Charalampopoulos A; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS FT, Sheffield, United Kingdom., Wild JM; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom.; INSIGNEO, Institute for in silico Medicine, University of Sheffield, Sheffield, United Kingdom., Condliffe R; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS FT, Sheffield, United Kingdom., Swift AJ; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom.; Department of Clinical Radiology, Sheffield Teaching Hospitals NHS FT, Sheffield, United Kingdom.; INSIGNEO, Institute for in silico Medicine, University of Sheffield, Sheffield, United Kingdom., Kiely DG; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom.; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS FT, Sheffield, United Kingdom.; INSIGNEO, Institute for in silico Medicine, University of Sheffield, Sheffield, United Kingdom.
Publikováno v:
Frontiers in medicine [Front Med (Lausanne)] 2022 Mar 14; Vol. 9, pp. 840196. Date of Electronic Publication: 2022 Mar 14 (Print Publication: 2022).
Autor:
Billings CG; Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom., Lewis R; Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom., Armstrong IJ; Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom., Hurdman JA; Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom., Smith IA; Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom., Austin M; Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom., Elliot CA; Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom., Charalampopoulos A; Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom., Sabroe I; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Medical School, Sheffield, United Kingdom., Lawrie A; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Medical School, Sheffield, United Kingdom., Thompson AAR; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Medical School, Sheffield, United Kingdom., Condliffe R; Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom., Kiely DG; Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom.; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Medical School, Sheffield, United Kingdom.; Insigneo Institute for in Silico Medicine, University of Sheffield, Sheffield, United Kingdom.
Publikováno v:
Frontiers in medicine [Front Med (Lausanne)] 2018 Jun 21; Vol. 5, pp. 172. Date of Electronic Publication: 2018 Jun 21 (Print Publication: 2018).
Autor:
Chin M; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Royal Hallamshire Hospital, Sheffield, United Kingdom., Johns C; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Royal Hallamshire Hospital, Sheffield, United Kingdom., Currie BJ; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Royal Hallamshire Hospital, Sheffield, United Kingdom., Weatherley N; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Royal Hallamshire Hospital, Sheffield, United Kingdom., Hill C; Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom., Elliot C; Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom., Rajaram S; Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom., Wild JM; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Royal Hallamshire Hospital, Sheffield, United Kingdom., Condliffe R; Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom., Bianchi S; Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom., Kiely DG; Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom., Swift AJ; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Royal Hallamshire Hospital, Sheffield, United Kingdom.; Institute for in silico Medicine, Sheffield, United Kingdom.
Publikováno v:
Frontiers in cardiovascular medicine [Front Cardiovasc Med] 2018 Jun 08; Vol. 5, pp. 53. Date of Electronic Publication: 2018 Jun 08 (Print Publication: 2018).
Autor:
Hickey PM; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom.; Pulmonary Vascular Diseases Unit, Royal Hallamshire Hospital, Sheffield, United Kingdom., Lawrie A; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom., Condliffe R; Pulmonary Vascular Diseases Unit, Royal Hallamshire Hospital, Sheffield, United Kingdom.
Publikováno v:
Frontiers in medicine [Front Med (Lausanne)] 2018 Jun 06; Vol. 5, pp. 175. Date of Electronic Publication: 2018 Jun 06 (Print Publication: 2018).
Autor:
Charalampopoulos A; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom., Lewis R; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom., Hickey P; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom., Durrington C; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom., Elliot C; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom., Condliffe R; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom., Sabroe I; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom., Kiely DG; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom.
Publikováno v:
Frontiers in medicine [Front Med (Lausanne)] 2018 Jun 06; Vol. 5, pp. 174. Date of Electronic Publication: 2018 Jun 06 (Print Publication: 2018).